PANTHERx® Rare Pharmacy Selected by ChemoCentryx to Distribute TAVNEOS™ (avacopan) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

[ad_1] PITTSBURGH, Oct. 14, 2021 /PRNewswire/ — PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as a limited distribution partner for new drug TAVNEOS (avacopan). TAVNEOS, an orally administered selective complement 5a receptor inhibitor, received FDA approval as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (also … Read more

OpenBench and HemoShear Therapeutics Agree to Pursue Rare Disease Target Using Artificial Intelligence

[ad_1] SAN FRANCISCO, Oct. 5, 2021 /PRNewswire/ — OpenBench, Inc., an emerging leader in AI-enabled small molecule discovery, entered into an agreement with HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, to use the OpenBench virtual screening platform to identify novel, potent inhibitors of an undisclosed rare disease target. Under the terms of … Read more

Often Mistaken For Asthma, This Rare Breathing Disorder Strikes Young Athletes : Shots

[ad_1] Dr. J. Tod Olin at National Jewish Hospital in Denver, treats patients with EILO, or for exercise-induced laryngeal obstruction. It’s a breathing disorder that affects young athletes especially. National Jewish Health hide caption toggle caption National Jewish Health Dr. J. Tod Olin at National Jewish Hospital in Denver, treats patients with EILO, or for … Read more